Mike West Interview Part 3: key flaw in stem cell field

Michael-West-PhD-CEO-of-BioTime-1-934x10241

I’m doing a series of posts on my recent conversation with BioTime CEO and pioneer of the stem cell field, Dr. Mike West. You can read Part 1 and Part 2 on Geron, ACT, and the history of the pluripotent stem cell field, particularly embryonic stem cells (ESCs). Today in Part 3, I am focusing on …

Mike West Interview Part 3: key flaw in stem cell field Read More »